Home LiteratureArticle Details
PMID: 8670807 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis.

The EMBO journal ·Vol. 15 ·No. 12 ·1996-06-17 ·Pages 3065-76

Rudolph B, Saffrich R, Zwicker J, Henglein B, Müller R, Ansorge W, Eilers M

Abstract

The activation of conditional alleles of Myc induces both cell proliferation and apoptosis in serum-deprived RAT1 fibroblasts. Entry into S phase and apoptosis are both preceded by increased levels of cyclin E- and cyclin D1-dependent kinase activities. To assess which, if any, cellular responses to Myc depend on active cyclin-dependent kinases (cdks), we have microinjected expression plasmids encoding the cdk inhibitors p16, p21 or p27, and have used a specific inhibitor of cdk2, roscovitine. Expression of cyclin A, which starts late in G1 phase, served as a marker for cell cycle progression. Our data show that active G1 cyclin/cdk complexes are both necessary and sufficient for induction of cyclin A by Myc. In contrast, neither microinjection of cdk inhibitors nor chemical inhibition of cdk2 affected the ability of Myc to induce apoptosis in serum-starved cells. Further, in isoleucine-deprived cells, Myc induces apoptosis without altering cdk activity. We conclude that Myc acts upstream of cdks in stimulating cell proliferation and also that activation of cdks and induction of apoptosis are largely independent events that occur in response to induction of Myc.

MeSH Terms
3T3 Cells Animals Apoptosis Base Sequence Cyclin-Dependent Kinases/metabolism Cyclins/genetics Enzyme Activation Genes, myc Mice Molecular Sequence Data Promoter Regions, Genetic RNA, Messenger Rats Transcriptional Activation
Chemicals
Cyclins RNA, Messenger Cyclin-Dependent Kinases
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Rudolph B
Zentrum für Molekulare Biologie Heidelberg (ZMBH), Germany.
Saffrich R
Zwicker J
Henglein B
Müller R
Ansorge W
Eilers M
References (90)
90 references, click to expand
  1. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation.
    EMBO J. 1994 Sep 1;13(17):4080-6 PMID: 8076603
  2. Mediation of c-Myc-induced apoptosis by p53.
    Science. 1994 Sep 30;265(5181):2091-3 PMID: 8091232
  3. Inhibition of cyclin-dependent kinases by purine analogues.
    Eur J Biochem. 1994 Sep 1;224(2):771-86 PMID: 7925396
  4. Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitions.
    FEBS Lett. 1994 Oct 17;353(2):207-11 PMID: 7523194
  5. Induction of p21 (WAF-1/CIP1) during differentiation.
    Oncogene. 1994 Nov;9(11):3389-96 PMID: 7936667
  6. Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest.
    Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10079-83 PMID: 7937841
  7. Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts.
    Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10412-6 PMID: 7937965
  8. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha.
    EMBO J. 1994 Nov 15;13(22):5442-50 PMID: 7957110
  9. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.
    Genes Dev. 1994 Oct 15;8(20):2441-52 PMID: 7958908
  10. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis.
    Mol Cell Biol. 1994 Dec;14(12):8166-73 PMID: 7969153
  11. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
    Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10918-22 PMID: 7971984
  12. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.
    Genes Dev. 1994 Dec 1;8(23):2817-30 PMID: 7995520
  13. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis.
    J Virol. 1995 Apr;69(4):2491-500 PMID: 7884898
  14. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.
    Cell. 1995 Mar 10;80(5):767-76 PMID: 7889570
  15. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.
    Genes Dev. 1993 Apr;7(4):546-54 PMID: 8384580
  16. The NF-M transcription factor is related to C/EBP beta and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells.
    EMBO J. 1993 Apr;12(4):1321-32 PMID: 8467792
  17. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen.
    Mol Endocrinol. 1993 Feb;7(2):232-40 PMID: 8469236
  18. Differential modulation of cyclin gene expression by MYC.
    Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3685-9 PMID: 8386381
  19. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.
    Cell Growth Differ. 1993 Feb;4(2):57-65 PMID: 8494784
  20. The ornithine decarboxylase gene is a transcriptional target of c-Myc.
    Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7804-8 PMID: 8356088
  21. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence.
    Genes Dev. 1992 Dec;6(12B):2513-23 PMID: 1340466
  22. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Oncogene. 1993 Dec;8(12):3447-57 PMID: 8247550
  23. D-type cyclin-dependent kinase activity in mammalian cells.
    Mol Cell Biol. 1994 Mar;14(3):2066-76 PMID: 8114738
  24. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
    Mol Cell Biol. 1994 Mar;14(3):2077-86 PMID: 8114739
  25. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    Cancer Res. 1994 Mar 1;54(5):1169-74 PMID: 8118801
  26. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.
    Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2026-30 PMID: 8134344
  27. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3.
    Cell. 1995 Mar 10;80(5):777-86 PMID: 7889571
  28. Transcriptional activation by Myc is under negative control by the transcription factor AP-2.
    EMBO J. 1995 Apr 3;14(7):1508-19 PMID: 7729426
  29. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.
    Nucleic Acids Res. 1995 May 25;23(10):1686-90 PMID: 7784172
  30. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.
    Genes Dev. 1995 Jul 15;9(14):1740-52 PMID: 7622038
  31. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes.
    Mol Cell Biol. 1995 Aug;15(8):4215-24 PMID: 7623816
  32. Rescue of defective mitogenic signaling by D-type cyclins.
    Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6837-41 PMID: 7624328
  33. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Genes Dev. 1995 Aug 1;9(15):1831-45 PMID: 7649471
  34. CDC25 phosphatases as potential human oncogenes.
    Science. 1995 Sep 15;269(5230):1575-7 PMID: 7667636
  35. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression.
    EMBO J. 1995 Sep 15;14(18):4514-22 PMID: 7556094
  36. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.
    EMBO J. 1995 Oct 2;14(19):4814-26 PMID: 7588611
  37. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases.
    Biol Cell. 1995;83(2-3):105-20 PMID: 7549905
  38. Expression of cyclin D1 mRNA is not upregulated by Myc in rat fibroblasts.
    Oncogene. 1995 Nov 2;11(9):1893-7 PMID: 7478619
  39. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site.
    Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11264-8 PMID: 7479977
  40. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
    Genes Dev. 1996 Feb 15;10(4):447-60 PMID: 8600028
  41. A link between cyclin A expression and adhesion-dependent cell cycle progression.
    Science. 1993 Dec 3;262(5139):1572-5 PMID: 8248807
  42. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Nature. 1993 Dec 16;366(6456):704-7 PMID: 8259215
  43. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max.
    EMBO J. 1993 Dec 15;12(13):5083-7 PMID: 8262051
  44. Distinct roles for cyclin-dependent kinases in cell cycle control.
    Science. 1993 Dec 24;262(5142):2050-4 PMID: 8266103
  45. c-Myc induces the expression and activity of ornithine decarboxylase.
    Cell Growth Differ. 1993 Nov;4(11):879-83 PMID: 8297793
  46. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
    Oncogene. 1994 Jan;9(1):323-6 PMID: 8302597
  47. Cellular oncogenes and multistep carcinogenesis.
    Science. 1983 Nov 18;222(4625):771-8 PMID: 6356358
  48. Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals.
    Cell. 1984 Dec;39(2 Pt 1):339-48 PMID: 6498938
  49. Definition of regions in human c-myc that are involved in transformation and nuclear localization.
    Mol Cell Biol. 1987 May;7(5):1697-709 PMID: 3299053
  50. Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.
    Genes Dev. 1989 Apr;3(4):527-36 PMID: 2721961
  51. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells.
    Nature. 1989 Jul 6;340(6228):66-8 PMID: 2662015
  52. Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor.
    Proc Natl Acad Sci U S A. 1989 Jul;86(14):5400-4 PMID: 2664783
  53. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.
    EMBO J. 1990 Sep;9(9):2811-8 PMID: 2118104
  54. Sequence-specific DNA binding by the c-Myc protein.
    Science. 1990 Nov 23;250(4984):1149-51 PMID: 2251503
  55. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region.
    Science. 1991 Jan 11;251(4990):186-9 PMID: 1987636
  56. The MYC protein activates transcription of the alpha-prothymosin gene.
    EMBO J. 1991 Jan;10(1):133-41 PMID: 1989881
  57. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Science. 1991 Mar 8;251(4998):1211-7 PMID: 2006410
  58. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation.
    Cell. 1991 May 3;65(3):395-407 PMID: 1840505
  59. Sequence-specific DNA binding by Myc proteins.
    Proc Natl Acad Sci U S A. 1991 May 15;88(10):4323-7 PMID: 1827916
  60. Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.
    Mol Cell Biol. 1991 Jul;11(7):3699-710 PMID: 2046673
  61. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
    Oncogene. 1991 Oct;6(10):1915-22 PMID: 1923514
  62. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts.
    Cell. 1991 Dec 20;67(6):1169-79 PMID: 1836977
  63. Myc and Max associate in vivo.
    Genes Dev. 1992 Jan;6(1):71-80 PMID: 1730411
  64. Max: functional domains and interaction with c-Myc.
    Genes Dev. 1992 Jan;6(1):81-92 PMID: 1730412
  65. Cyclin A is required at two points in the human cell cycle.
    EMBO J. 1992 Mar;11(3):961-71 PMID: 1312467
  66. Induction of apoptosis in fibroblasts by c-myc protein.
    Cell. 1992 Apr 3;69(1):119-28 PMID: 1555236
  67. Reciprocal regulation of adipogenesis by Myc and C/EBP alpha.
    Science. 1992 Apr 17;256(5055):379-82 PMID: 1566086
  68. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7742-6 PMID: 1457005
  69. Dominant negative MYC blocks transformation by ABL oncogenes.
    Cell. 1992 Sep 18;70(6):901-10 PMID: 1525828
  70. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.
    Nature. 1992 Oct 1;359(6394):423-6 PMID: 1406955
  71. Myc and Max proteins possess distinct transcriptional activities.
    Nature. 1992 Oct 1;359(6394):426-9 PMID: 1406956
  72. The functions of Myc proteins.
    Biochim Biophys Acta. 1992 Dec 16;1114(2-3):129-46 PMID: 1457461
  73. Sequence-specific transcriptional activation by Myc and repression by Max.
    Mol Cell Biol. 1993 Jan;13(1):383-90 PMID: 8417337
  74. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
    Cell. 1993 Jan 29;72(2):211-22 PMID: 8425218
  75. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.
    Cell. 1993 Jan 29;72(2):223-32 PMID: 8425219
  76. Oncogenic activity of the c-Myc protein requires dimerization with Max.
    Cell. 1993 Jan 29;72(2):233-45 PMID: 8425220
  77. Cyclin E and cyclin A as candidates for the restriction point protein.
    Cancer Res. 1993 Apr 1;53(7):1493-7 PMID: 8384078
  78. Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2.
    Mol Cell Biol. 1993 Apr;13(4):2432-40 PMID: 8455620
  79. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.
    Cell. 1994 Mar 25;76(6):1013-23 PMID: 8137420
  80. Binding and suppression of the Myc transcriptional activation domain by p107.
    Science. 1994 Apr 8;264(5156):251-4 PMID: 8146655
  81. p53 and E2F-1 cooperate to mediate apoptosis.
    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3602-6 PMID: 8170954
  82. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
    J Cell Biol. 1994 May;125(3):625-38 PMID: 8175885
  83. An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc.
    Mol Cell Biol. 1994 Jun;14(6):3853-62 PMID: 8196628
  84. Repression of cyclin D1: a novel function of MYC.
    Mol Cell Biol. 1994 Jun;14(6):4032-43 PMID: 8196642
  85. Structure and cell cycle-regulated transcription of the human cyclin A gene.
    Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5490-4 PMID: 8202514
  86. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oncogene. 1994 Jul;9(7):2029-36 PMID: 8208548
  87. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
    Cell. 1994 Jul 15;78(1):59-66 PMID: 8033212
  88. Participation of cyclin A in Myc-induced apoptosis.
    Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6875-9 PMID: 8041712
  89. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.
    EMBO J. 1994 Jul 15;13(14):3286-95 PMID: 8045259
  90. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis.
    Mol Cell Biol. 1994 Sep;14(9):5741-7 PMID: 8065308
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1996-06-17
Pages
3065-76
Language
English
Region
England
NLM ID
8208664
PMCID
PMC450247
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com